{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:07:17Z","timestamp":1774314437665,"version":"3.50.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with systemic lupus erythematosus (SLE) are predisposed to Epstein\u2013Barr virus (EBV) reactivation and the subsequent development of lymphoproliferative disorders (LPDs) due to immune dysregulation and prolonged immunosuppressive therapy. We report a case of a 42-year-old woman with a 26-year history of SLE who had been clinically stable for several years on low-dose prednisolone, azathioprine, cyclosporine, and hydroxychloroquine. She presented for evaluation of persistent fevers and abdominal pain. Imaging studies revealed segmental small bowel thickening with mesenteric hyperaemia, suggestive of lupus enteritis. Laboratory findings included hypoalbuminemia and elevated inflammatory markers, but no serologic evidence of active lupus. Histologic examination of small intestinal biopsies revealed a polymorphic lymphoid infiltrate with atypical B cells positive for EBV, leading to a diagnosis of EBV-associated LPD. Following a reduction in immunosuppressive therapy and initiation of rituximab, the patient achieved clinical and radiologic improvement. This case highlights the importance of considering EBV-LPD in the differential diagnosis of gastrointestinal manifestations in SLE patients, particularly when serologic markers of active lupus are absent. The overlapping clinical and imaging features of lupus enteritis and EBV-LPD can lead to diagnostic delays, making histopathologic assessment crucial for accurate identification. The case also underscores the potential risk of EBV-LPD associated with long-term immunosuppressive treatment in SLE. Careful monitoring for lymphoproliferative complications is warranted in patients undergoing sustained immunosuppression.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag010","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:19:04Z","timestamp":1770880744000},"source":"Crossref","is-referenced-by-count":1,"title":["Intestinal Epstein\u2013Barr virus-associated lymphoproliferative disorder mimicking lupus enteritis in a systemic lupus erythematosus patient: A case report"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5390-9107","authenticated-orcid":false,"given":"Mitsuhisa","family":"Oikawa","sequence":"first","affiliation":[{"name":"Department of Allergy and Rheumatology, The University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2860-8261","authenticated-orcid":false,"given":"Nanami","family":"Mino","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, The University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, The University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4907-4647","authenticated-orcid":false,"given":"Mitsuaki","family":"Oura","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, The University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Tokushige","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, The University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-7656","authenticated-orcid":false,"given":"Haruka","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, The University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-5254","authenticated-orcid":false,"given":"Keishi","family":"Fujio","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, The University of Tokyo Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"2026022709414270700_ref1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: incidence, pathogenesis and biology","volume":"75","author":"Klein","year":"2018","journal-title":"Leuk Res"},{"key":"2026022709414270700_ref2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","article-title":"BILAG 2004 development and initial validation of an updated version of the British Isles Lupus Assessment Group\u2019s disease activity index for patients with systemic lupus erythematosus","volume":"44","author":"Isenberg","year":"2005","journal-title":"Rheumatology"},{"key":"2026022709414270700_ref3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.rdc.2017.09.011","article-title":"Gastrointestinal and hepatic disease in systemic lupus erythematosus","volume":"44","author":"Brewer","year":"2018","journal-title":"Rheum Dis Clin N Am"},{"key":"2026022709414270700_ref4","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/rheumatology\/kead689","article-title":"Lupus enteritis: a narrative review","volume":"63","author":"Mu\u00f1oz-Urbano","year":"2024","journal-title":"Rheumatology"},{"key":"2026022709414270700_ref5","volume-title":"Haematolymphoid Tumours. WHO Classification of Tumours","year":"2024","edition":"5th"},{"key":"2026022709414270700_ref6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1750-1172-8-67","article-title":"Lupus enteritis: from clinical findings to therapeutic management","volume":"8","author":"Janssens","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2026022709414270700_ref7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1148\/radiology.211.1.r99mr17203","article-title":"CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease","volume":"211","author":"Byun","year":"1999","journal-title":"Radiology"},{"key":"2026022709414270700_ref8","doi-asserted-by":"crossref","first-page":"1526633","DOI":"10.3389\/fcimb.2024.1526633","article-title":"Plasma Epstein-Barr virus DNA load for diagnostic and prognostic assessment in intestinal Epstein-Barr virus infection","volume":"14","author":"Ma","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"2026022709414270700_ref9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","article-title":"Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus","volume":"172","author":"Kang","year":"2004","journal-title":"J Immunol"},{"key":"2026022709414270700_ref10","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.4049\/jimmunol.174.11.6599","article-title":"EBV and systemic lupus erythematosus: a new perspective","volume":"174","author":"Gross","year":"2005","journal-title":"J Immunol"},{"key":"2026022709414270700_ref11","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1016\/j.cell.2024.08.025","article-title":"Neoself-antigens are the primary target for autoreactive T cells in human lupus","volume":"187","author":"Mori","year":"2024","journal-title":"Cell"},{"key":"2026022709414270700_ref12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026022709414270700_ref13","doi-asserted-by":"crossref","first-page":"100807","DOI":"10.1016\/j.blre.2021.100807","article-title":"Clinical features and treatment strategies for post-transplant and iatrogenic immunodeficiency-associated lymphoproliferative disorders","volume":"49","author":"Ohmoto","year":"2021","journal-title":"Blood Rev"},{"key":"2026022709414270700_ref14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/art.42809","article-title":"Effect of recent antirheumatic drug on features of rheumatoid arthritis\u2013associated lymphoproliferative disorders","volume":"76","author":"Hoshida","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026022709414270700_ref15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"2026022709414270700_ref16","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/ajg.2009.745","article-title":"Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case\u2013control study","volume":"105","author":"Armstrong","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2026022709414270700_ref17","doi-asserted-by":"crossref","first-page":"151503","DOI":"10.1016\/j.semnephrol.2024.151503","article-title":"Post-transplant lymphoproliferative disorders","volume":"44","author":"Dharnidharka","year":"2024","journal-title":"Semin Nephrol"},{"key":"2026022709414270700_ref18","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours, Revised","author":"Swerdlow","year":"2017","edition":"4th"},{"key":"2026022709414270700_ref19","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag010\/66856365\/rxag010.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag010\/66856365\/rxag010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag010\/66856365\/rxag010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:41:49Z","timestamp":1772203309000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag010\/8473525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag010","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag010"}}